Are we there yet? The road to faster and more efficient CAR T cell manufacturing
Artículo
Acceso abierto
Artículo
DOAJ
Abstract Chimeric antigen receptor (CAR) T cell therapies have achieved clinical success in autologous treatment of hematological malignancies. However, their broader application remains limited. Beyond the biological ch...
LCC LCC:Biology (General)Idioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access